DANTROLENE

DANTROLENE was reported 1145 times

DANTROLENE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GIARDIA TEST POSITIVE 1 0.0909
1 PLETHORIC FACE 2 0.0690
2 MALIGNANT CATATONIA 9 0.0342
3 HEAD AND NECK CANCER STAGE IV 1 0.0294
4 LOCOMOTIVE SYNDROME 1 0.0270
5 REACTIVE PERFORATING COLLAGENOSIS 1 0.0270
6 URINE COPPER INCREASED 1 0.0250
7 ACQUIRED AMINOACIDURIA 1 0.0244
8 LOWER MOTOR NEURONE LESION 1 0.0189
9 LACRIMAL HAEMORRHAGE 1 0.0172
10 MYOGLOBINAEMIA 2 0.0169
11 CSF VOLUME INCREASED 2 0.0168
12 CHEYNE-STOKES RESPIRATION 4 0.0161
13 HYPERRESPONSIVE TO STIMULI 1 0.0159
14 REVERSIBLE SPLENIAL LESION SYNDROME 1 0.0156
15 MYOTONIA 3 0.0135
16 ANISOCORIA 5 0.0132
17 CARNITINE DECREASED 1 0.0122
18 VASCULAR ACCESS SITE EXTRAVASATION 1 0.0115
19 HYPERTHERMIA MALIGNANT 17 0.0114
20 SELECTIVE IGG SUBCLASS DEFICIENCY 1 0.0106
21 HAEMODILUTION 1 0.0101
22 POSTOPERATIVE DELIRIUM 2 0.0101
23 VERBIGERATION 1 0.0098
24 MENTAL STATUS CHANGES POSTOPERATIVE 1 0.0094
25 SERRATIA SEPSIS 1 0.0093
26 TYPE II HYPERSENSITIVITY 1 0.0084
27 TRACHEOSTOMY INFECTION 1 0.0082
28 NEUROLEPTIC MALIGNANT SYNDROME 96 0.0081
29 BETA 2 MICROGLOBULIN URINE INCREASED 1 0.0070
30 LABILE BLOOD PRESSURE 8 0.0067
31 BLOOD CREATININE 1 0.0065
32 INCREASED DOSE ADMINISTERED 2 0.0064
33 ACQUIRED OESOPHAGEAL WEB 2 0.0059
34 PARKINSONISM HYPERPYREXIA SYNDROME 1 0.0056
35 HYPOMETABOLISM 2 0.0052
36 STREPTOCOCCAL URINARY TRACT INFECTION 1 0.0052
37 IMPLANT SITE ABSCESS 1 0.0052
38 UTERINE CERVICAL PAIN 1 0.0051
39 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 2 0.0050
40 PERSISTENT DEPRESSIVE DISORDER 2 0.0050
41 EXPOSURE VIA INHALATION 1 0.0046
42 HISTAMINE LEVEL INCREASED 1 0.0046
43 UPPER MOTOR NEURONE LESION 1 0.0045
44 GLOMERULAR FILTRATION RATE ABNORMAL 6 0.0042
45 DRUG-DISEASE INTERACTION 3 0.0041
46 INTUBATION 1 0.0040
47 HYPERMETABOLISM 2 0.0038
48 ANTICHOLINERGIC SYNDROME 6 0.0038
49 HYPERTHERMIA 28 0.0037
50 CULTURE STOOL POSITIVE 1 0.0036
51 DUODENOGASTRIC REFLUX 1 0.0036
52 OESOPHAGEAL OEDEMA 1 0.0035
53 BACTERIAL VULVOVAGINITIS 1 0.0035
54 EOSINOPHILIC PLEURAL EFFUSION 1 0.0034
55 SYSTEMIC MASTOCYTOSIS 1 0.0033
56 STOMA SITE HYPERGRANULATION 2 0.0032
57 EUTHANASIA 1 0.0032
58 PLASTIC SURGERY 1 0.0031
59 COMMINUTED FRACTURE 1 0.0030
60 INGUINAL HERNIA REPAIR 1 0.0030
61 MULTIPLE SCLEROSIS PSEUDO RELAPSE 1 0.0029
62 CHOREOATHETOSIS 2 0.0029
63 GIARDIASIS 1 0.0029
64 CHOLURIA 1 0.0029
65 STIFF PERSON SYNDROME 1 0.0029
66 MUSCLE HYPERTROPHY 1 0.0028
67 PROTEUS INFECTION 2 0.0028
68 VAGINAL FISTULA 1 0.0028
69 SYMPTOM MASKED 2 0.0027
70 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8 0.0027
71 MUSCLE CONTRACTURE 5 0.0025
72 GLIOSIS 1 0.0023
73 ENCEPHALITIS AUTOIMMUNE 3 0.0023
74 KYPHOSIS 4 0.0023
75 DOPAMINE DYSREGULATION SYNDROME 1 0.0022
76 EHLERS-DANLOS SYNDROME 1 0.0022
77 CATATONIA 11 0.0021
78 MUSCLE RIGIDITY 25 0.0021
79 BLOOD URINE 2 0.0021
80 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0021
81 BLOOD URIC ACID DECREASED 1 0.0021
82 MOTOR NEURONE DISEASE 1 0.0021
83 HYPOFIBRINOGENAEMIA 2 0.0020
84 HYPERREFLEXIA 7 0.0020
85 HYPERTROPHY 1 0.0018
86 CLONUS 5 0.0018
87 MYOCARDIAL INJURY 2 0.0018
88 APNOEIC ATTACK 1 0.0018
89 BILIARY COLIC 5 0.0017
90 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
91 URINARY TRACT INFECTION PSEUDOMONAL 1 0.0017
92 NEUROPSYCHOLOGICAL SYMPTOMS 1 0.0017
93 MEDICAL DEVICE SITE INFECTION 1 0.0016
94 INTRADUCTAL PROLIFERATIVE BREAST LESION 2 0.0016
95 FORCED VITAL CAPACITY DECREASED 1 0.0015
96 MULTI-ORGAN DISORDER 3 0.0015
97 SPUTUM ABNORMAL 1 0.0015
98 INFUSION SITE URTICARIA 1 0.0015
99 BRONCHITIS VIRAL 1 0.0015
100 CALCULUS BLADDER 2 0.0015
101 PROPOFOL INFUSION SYNDROME 1 0.0014
102 FANCONI SYNDROME 2 0.0014
103 HYPERNATRAEMIA 7 0.0014
104 HYPERTONIC BLADDER 4 0.0014
105 MUTISM 2 0.0014
106 MULTIPLE DRUG THERAPY 1 0.0013
107 MYOCLONIC EPILEPSY 2 0.0013
108 HAEMODYNAMIC INSTABILITY 10 0.0013
109 DIAPHRAGMATIC DISORDER 1 0.0013
110 ELECTROCARDIOGRAM PR PROLONGATION 1 0.0013
111 MYOGLOBIN BLOOD INCREASED 2 0.0013
112 PNEUMONIA MYCOPLASMAL 1 0.0013
113 MAMMOPLASTY 1 0.0013
114 ANTICONVULSANT DRUG LEVEL INCREASED 2 0.0012
115 POSTURE ABNORMAL 4 0.0012
116 HYPOVENTILATION 4 0.0012
117 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
118 CULTURE POSITIVE 1 0.0012
119 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
120 MUSCLE SPASTICITY 14 0.0011
121 OOPHORECTOMY 1 0.0011
122 CANDIDA SEPSIS 1 0.0011
123 FIBROMA 1 0.0011
124 EXTENSOR PLANTAR RESPONSE 1 0.0011
125 SKIN GRAFT 1 0.0011
126 BLADDER SPASM 2 0.0011
127 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 2 0.0011
128 NARCOLEPSY 2 0.0011
129 INFECTED SKIN ULCER 2 0.0011
130 LUMBAR SPINAL STENOSIS 3 0.0010
131 RESPIRATORY ACIDOSIS 4 0.0010
132 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
133 WALKING DISABILITY 2 0.0010
134 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
135 NON-CARDIOGENIC PULMONARY OEDEMA 1 0.0009
136 NYSTAGMUS 5 0.0009
137 BLOOD SODIUM ABNORMAL 1 0.0009
138 ALLERGY TO ANIMAL 1 0.0009
139 ORCHITIS 1 0.0009
140 INFUSION SITE MASS 1 0.0009
141 MENINGITIS ASEPTIC 4 0.0009
142 MOANING 1 0.0009
143 THROMBOPHLEBITIS 3 0.0009
144 COCCIDIOIDOMYCOSIS 1 0.0008
145 ESCHERICHIA TEST POSITIVE 1 0.0008
146 INFECTED CYST 1 0.0008
147 SEROTONIN SYNDROME 16 0.0008
148 DIABETES INSIPIDUS 2 0.0008
149 PANCREATIC DISORDER 4 0.0008
150 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0008
151 BLEPHAROSPASM 5 0.0008
152 MENOPAUSE 2 0.0008
153 DYSTONIA 15 0.0008
154 COMPARTMENT SYNDROME 2 0.0008
155 PRODUCT DELIVERY MECHANISM ISSUE 4 0.0007
156 RHABDOMYOLYSIS 31 0.0007
157 TACHYPNOEA 10 0.0007
158 ISCHAEMIC HEPATITIS 1 0.0007
159 INFUSION SITE RASH 1 0.0007
160 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
161 TONIC CONVULSION 1 0.0007
162 HYPERTONIA 4 0.0007
163 PELVIC VENOUS THROMBOSIS 1 0.0007
164 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
165 CREPITATIONS 2 0.0007
166 HYPERCAPNIA 2 0.0007
167 EMBOLISM VENOUS 2 0.0007
168 HEAT STROKE 1 0.0007
169 BACTERIAL VAGINOSIS 1 0.0006
170 OPHTHALMOPLEGIA 1 0.0006
171 BLADDER PAIN 2 0.0006
172 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
173 SPINAL CORD DISORDER 1 0.0006
174 SYSTEMIC INFECTION 1 0.0006
175 TROPONIN I INCREASED 1 0.0006
176 RECTAL ABSCESS 1 0.0006
177 POTENTIATING DRUG INTERACTION 2 0.0006
178 EROSIVE OESOPHAGITIS 1 0.0006
179 GAZE PALSY 1 0.0006
180 DIFFICULTY IN WALKING 2 0.0006
181 TRISMUS 3 0.0006
182 CHOREA 1 0.0006
183 BLOOD CHLORIDE INCREASED 1 0.0006
184 HYPERAMMONAEMIC ENCEPHALOPATHY 1 0.0006
185 SPINAL CORD INJURY 1 0.0006
186 PSEUDOMONAL SEPSIS 1 0.0006
187 INFUSION SITE DISCHARGE 1 0.0006
188 FANCONI SYNDROME ACQUIRED 1 0.0006
189 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
190 INCONTINENCE 6 0.0006
191 VENTRICULAR ARRHYTHMIA 2 0.0005
192 METAMORPHOPSIA 1 0.0005
193 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
194 STOMA SITE ERYTHEMA 1 0.0005
195 IMPULSIVE BEHAVIOUR 2 0.0005
196 MECHANICAL VENTILATION 1 0.0005
197 PYELONEPHRITIS ACUTE 1 0.0005
198 NAIL DISCOLOURATION 2 0.0005
199 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
200 LEUKOCYTOSIS 9 0.0005
201 BREAST DISORDER 1 0.0005
202 POLYCYTHAEMIA 1 0.0005
203 PSYCHOTIC SYMPTOM 1 0.0005
204 SPINAL STENOSIS 2 0.0005
205 SPINAL COMPRESSION FRACTURE 4 0.0005
206 IMPAIRED SELF-CARE 1 0.0005
207 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
208 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 26 0.0005
209 NEUROGENIC BLADDER 1 0.0005
210 SLEEP DEFICIT 1 0.0005
211 EAR SWELLING 1 0.0005
212 HYPERPYREXIA 2 0.0005
213 TORTICOLLIS 1 0.0005
214 SCREAMING 3 0.0005
215 INFUSION SITE BRUISING 1 0.0005
216 IMMOBILE 2 0.0005
217 CLOSTRIDIUM TEST POSITIVE 1 0.0005
218 WHEELCHAIR USER 2 0.0004
219 INFECTIOUS MONONUCLEOSIS 1 0.0004
220 DISTRIBUTIVE SHOCK 1 0.0004
221 EYELID DISORDER 1 0.0004
222 IMPLANT SITE INFECTION 1 0.0004
223 NECK SURGERY 1 0.0004
224 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
225 EOSINOPHIL COUNT DECREASED 1 0.0004
226 URINARY HESITATION 1 0.0004
227 RESPIRATORY DEPRESSION 5 0.0004
228 DENTAL OPERATION 1 0.0004
229 HYPERVOLAEMIA 2 0.0004
230 URINARY TRACT INFECTION BACTERIAL 1 0.0004
231 BRAIN ABSCESS 1 0.0004
232 MYDRIASIS 5 0.0004
233 FOETAL DEATH 2 0.0004
234 MULTIPLE ALLERGIES 3 0.0004
235 AREFLEXIA 1 0.0004
236 HYPERLACTACIDAEMIA 1 0.0004
237 BLOOD SODIUM INCREASED 1 0.0004
238 DRUG TOXICITY 5 0.0004
239 STOMA SITE DISCHARGE 1 0.0004
240 ASPIRATION 4 0.0004
241 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
242 LUNG CONSOLIDATION 1 0.0004
243 ENDOTRACHEAL INTUBATION 1 0.0004
244 PSYCHOMOTOR RETARDATION 1 0.0004
245 RENAL TUBULAR DISORDER 1 0.0004
246 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
247 FIBULA FRACTURE 1 0.0003
248 DELIRIUM 12 0.0003
249 METABOLIC DISORDER 2 0.0003
250 RALES 2 0.0003
251 HYPERKALAEMIA 12 0.0003
252 HYPERTRIGLYCERIDAEMIA 2 0.0003
253 STRABISMUS 1 0.0003
254 BLOOD CULTURE POSITIVE 1 0.0003
255 HALLUCINATION, VISUAL 7 0.0003
256 NO THERAPEUTIC RESPONSE 4 0.0003
257 DYSAESTHESIA 1 0.0003
258 DUODENITIS 1 0.0003
259 UROSEPSIS 3 0.0003
260 MENTAL STATUS CHANGES 9 0.0003
261 MULTIPLE-DRUG RESISTANCE 1 0.0003
262 INVESTIGATION 1 0.0003
263 HEPATOTOXICITY 7 0.0003
264 METABOLIC ACIDOSIS 10 0.0003
265 STUPOR 1 0.0003
266 PROCTALGIA 2 0.0003
267 MUSCLE TIGHTNESS 5 0.0003
268 SEDATION 8 0.0003
269 SHOCK 7 0.0003
270 INFUSION SITE HAEMORRHAGE 1 0.0003
271 WALKING AID USER 2 0.0003
272 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
273 BLADDER DISORDER 3 0.0003
274 CYTOLYTIC HEPATITIS 1 0.0003
275 THERAPEUTIC AGENT TOXICITY 1 0.0003
276 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
277 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
278 WOUND DEHISCENCE 1 0.0003
279 CLOSTRIDIAL INFECTION 1 0.0003
280 SUBARACHNOID HAEMORRHAGE 3 0.0003
281 EYE MOVEMENT DISORDER 2 0.0003
282 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
283 THERAPY NON-RESPONDER 13 0.0003
284 TACHYPHRENIA 1 0.0003
285 DEPRESSIVE SYMPTOM 1 0.0003
286 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
287 HAEMORRHAGIC DIATHESIS 1 0.0003
288 PNEUMONIA ASPIRATION 7 0.0003
289 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
290 BLOOD PHOSPHORUS DECREASED 1 0.0003
291 ORAL DISORDER 2 0.0003
292 UNRESPONSIVE TO STIMULI 7 0.0003
293 DYSKINESIA 11 0.0003
294 TACHYCARDIA 24 0.0003
295 DYSARTHRIA 10 0.0003
296 STATUS EPILEPTICUS 3 0.0003
297 OESOPHAGEAL ULCER 1 0.0003
298 HAEMOLYSIS 2 0.0003
299 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
300 APNOEA 2 0.0003
301 PULMONARY HAEMORRHAGE 2 0.0003
302 CEREBRAL ATROPHY 1 0.0003
303 BLEPHARITIS 1 0.0002
304 FUNGAL SKIN INFECTION 1 0.0002
305 HOMICIDAL IDEATION 1 0.0002
306 DECUBITUS ULCER 2 0.0002
307 DEMYELINATION 1 0.0002
308 ESCHERICHIA INFECTION 2 0.0002
309 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
310 BRAIN OEDEMA 3 0.0002
311 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
312 CIRCULATORY COLLAPSE 4 0.0002
313 RESPIRATORY FAILURE 17 0.0002
314 PULMONARY FUNCTION TEST DECREASED 1 0.0002
315 BEDRIDDEN 3 0.0002
316 HAEMORRHAGIC ANAEMIA 1 0.0002
317 BLOOD CREATINE INCREASED 1 0.0002
318 OSTEOMYELITIS 4 0.0002
319 IMMUNE THROMBOCYTOPENIA 1 0.0002
320 AGITATION 16 0.0002
321 OVARIAN CANCER 2 0.0002
322 GRAND MAL CONVULSION 2 0.0002
323 ARTHRITIS INFECTIVE 1 0.0002
324 SPINAL COLUMN STENOSIS 1 0.0002
325 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
326 SUBCUTANEOUS ABSCESS 1 0.0002
327 APHAGIA 1 0.0002
328 VULVOVAGINAL PAIN 1 0.0002
329 APATHY 3 0.0002
330 PARKINSONISM 2 0.0002
331 FOOT OPERATION 1 0.0002
332 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
333 PRESCRIBED UNDERDOSE 4 0.0002
334 BRAIN INJURY 2 0.0002
335 DRUG TOLERANCE 1 0.0002
336 DYSPHORIA 1 0.0002
337 HYPOTHERMIA 2 0.0002
338 TOXIC ENCEPHALOPATHY 1 0.0002
339 PATHOLOGICAL FRACTURE 1 0.0002
340 PETIT MAL EPILEPSY 1 0.0002
341 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
342 PHLEBITIS 1 0.0002
343 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
344 PARTIAL SEIZURES 1 0.0002
345 MULTIPLE SCLEROSIS RELAPSE 13 0.0002
346 BRUXISM 1 0.0002
347 HIP SURGERY 1 0.0002
348 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
349 NORMAL NEWBORN 1 0.0002
350 HYDROCEPHALUS 1 0.0002
351 WOUND INFECTION 2 0.0002
352 DRUG LEVEL INCREASED 3 0.0002
353 ON AND OFF PHENOMENON 1 0.0002
354 VENTRICULAR FIBRILLATION 2 0.0002
355 GAIT INABILITY 6 0.0002
356 INTERMENSTRUAL BLEEDING 1 0.0002
357 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
358 DRUG INTERACTION 28 0.0002
359 PERONEAL NERVE PALSY 1 0.0002
360 MYOCARDIAL ISCHAEMIA 2 0.0002
361 NEUROLOGICAL SYMPTOM 1 0.0002
362 PARANOIA 3 0.0002
363 SKIN ATROPHY 1 0.0002
364 HERPES VIRUS INFECTION 1 0.0002
365 MULTI-ORGAN FAILURE 3 0.0002
366 HYPERVENTILATION 1 0.0002
367 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
368 ATAXIA 2 0.0002
369 ACCIDENT 2 0.0002
370 HYPERLIPIDAEMIA 2 0.0002
371 POLYNEUROPATHY 2 0.0002
372 HEPATITIS B 1 0.0002
373 OEDEMA 9 0.0002
374 TENSION 1 0.0002
375 RESTLESSNESS 6 0.0002
376 LARYNGEAL OEDEMA 1 0.0002
377 ABASIA 4 0.0002
378 CYST 2 0.0002
379 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
380 AGGRESSION 8 0.0002
381 HYPOCALCAEMIA 3 0.0002
382 GASTRIC ULCER 3 0.0002
383 THERAPEUTIC RESPONSE CHANGED 1 0.0002
384 HEPATIC CYTOLYSIS 2 0.0002
385 INFUSION SITE PAIN 2 0.0002
386 MENINGITIS 1 0.0001
387 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
388 SEIZURE 17 0.0001
389 GINGIVAL BLEEDING 2 0.0001
390 OSTEOPOROSIS 6 0.0001
391 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
392 LARGE INTESTINE POLYP 1 0.0001
393 FORMICATION 1 0.0001
394 CARPAL TUNNEL SYNDROME 2 0.0001
395 HYPOXIA 5 0.0001
396 TARDIVE DYSKINESIA 4 0.0001
397 SEASONAL ALLERGY 2 0.0001
398 HAND FRACTURE 1 0.0001
399 CONVULSION 8 0.0001
400 LIVER FUNCTION TEST INCREASED 3 0.0001
401 LETHARGY 8 0.0001
402 DEEP VEIN THROMBOSIS 9 0.0001
403 HYPERTHYROIDISM 2 0.0001
404 PRODUCT PRESCRIBING ISSUE 3 0.0001
405 DYSSTASIA 4 0.0001
406 PSYCHIATRIC SYMPTOM 1 0.0001
407 URINARY TRACT INFECTION 23 0.0001
408 DUODENAL ULCER PERFORATION 1 0.0001
409 EYE SWELLING 5 0.0001
410 CARDIAC ARREST 11 0.0001
411 PAROSMIA 1 0.0001
412 ECONOMIC PROBLEM 2 0.0001
413 DEVICE FAILURE 2 0.0001
414 ACIDOSIS 1 0.0001
415 TOXICITY TO VARIOUS AGENTS 22 0.0001
416 FOOD ALLERGY 1 0.0001
417 FEMUR FRACTURE 4 0.0001
418 HYPOALBUMINAEMIA 1 0.0001
419 TREMOR 21 0.0001
420 RENAL CYST 1 0.0001
421 HALLUCINATION, AUDITORY 2 0.0001
422 ATRIAL FLUTTER 1 0.0001
423 BLOOD DISORDER 1 0.0001
424 OXYGEN SATURATION DECREASED 7 0.0001
425 MYASTHENIA GRAVIS 1 0.0001
426 MUSCLE DISORDER 1 0.0001
427 NEURALGIA 3 0.0001
428 ABNORMAL FAECES 1 0.0001
429 HICCUPS 1 0.0001
430 STAPHYLOCOCCAL INFECTION 4 0.0001
431 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
432 DRUG ABUSE 10 0.0001
433 COAGULOPATHY 2 0.0001
434 RENAL IMPAIRMENT 10 0.0001
435 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
436 INFUSION SITE ERYTHEMA 1 0.0001
437 HEMIPARESIS 2 0.0001
438 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
439 VITAMIN D DECREASED 1 0.0001
440 THERAPY CESSATION 6 0.0001
441 MUSCLE STRAIN 1 0.0001
442 DIPLOPIA 3 0.0001
443 HYSTERECTOMY 1 0.0001
444 MENTAL DISORDER 5 0.0001
445 ORTHOSTATIC HYPOTENSION 2 0.0001
446 SPEECH DISORDER 6 0.0001
447 MUSCLE SPASMS 21 0.0001
448 IMMUNOSUPPRESSION 1 0.0001
449 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
450 RESPIRATORY RATE INCREASED 1 0.0001
451 GALLBLADDER DISORDER 2 0.0001
452 GASTROINTESTINAL INFECTION 1 0.0001
453 ANAL INCONTINENCE 1 0.0001
454 OPTIC NEURITIS 1 0.0001
455 MOOD ALTERED 3 0.0001
456 HIDRADENITIS 1 0.0001
457 HYPERHIDROSIS 14 0.0001
458 NEPHROPATHY 1 0.0001
459 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
460 HYPONATRAEMIA 6 0.0001
461 SPINAL DISORDER 1 0.0001
462 POISONING DELIBERATE 1 0.0001
463 MULTIPLE SCLEROSIS 5 0.0001
464 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
465 AFFECT LABILITY 1 0.0001
466 HYPERCHOLESTEROLAEMIA 1 0.0001
467 HAEMORRHOIDS 2 0.0001
468 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
469 BODY TEMPERATURE DECREASED 1 0.0001
470 LIGAMENT SPRAIN 1 0.0001
471 ABNORMAL BEHAVIOUR 4 0.0001
472 IRRITABILITY 6 0.0001
473 HYPOTENSION 20 0.0001
474 APHASIA 3 0.0001
475 CELLULITIS 5 0.0001
476 HYPERTENSION 21 0.0001
477 MOTOR DYSFUNCTION 1 0.0001
478 BODY TEMPERATURE INCREASED 2 0.0001
479 NEUTROPHIL COUNT INCREASED 1 0.0001
480 EMOTIONAL DISORDER 3 0.0001
481 TEMPERATURE INTOLERANCE 1 0.0001
482 WITHDRAWAL SYNDROME 4 0.0001
483 SCRATCH 1 0.0001
484 PULMONARY EMBOLISM 9 0.0001
485 HYPOTHYROIDISM 3 0.0001
486 INTENTIONAL OVERDOSE 6 0.0001
487 BALANCE DISORDER 8 0.0001
488 OESOPHAGITIS 1 0.0001
489 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
490 MUSCULOSKELETAL STIFFNESS 8 0.0001
491 TOOTH FRACTURE 1 0.0001
492 DENTAL CARIES 1 0.0001
493 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
494 TRANSAMINASES INCREASED 2 0.0001
495 BLOOD CALCIUM DECREASED 1 0.0001
496 FLUSHING 9 0.0001
497 MUSCULAR WEAKNESS 10 0.0001
498 SCAB 1 0.0001
499 MICTURITION URGENCY 1 0.0001
500 MUSCLE TWITCHING 2 0.0001
501 PYREXIA 30 0.0001
502 HYPOKALAEMIA 4 0.0001
503 CONFUSIONAL STATE 14 0.0001
504 COGNITIVE DISORDER 4 0.0001
505 ACUTE KIDNEY INJURY 13 0.0001
506 COMA 4 0.0001
507 MYOCLONUS 1 0.0001
508 MACULAR DEGENERATION 1 0.0001
509 RENAL FAILURE 11 0.0001
510 HEPATITIS C 1 0.0001
511 THERAPEUTIC RESPONSE DECREASED 5 0.0001
512 ADRENAL INSUFFICIENCY 1 0.0001
513 CYTOPENIA 1 0.0001
514 ENCEPHALOPATHY 2 0.0001
515 SMALL INTESTINAL OBSTRUCTION 1 0.0001
516 SPINAL OPERATION 1 0.0001
517 INJECTION SITE MASS 3 0.0001
518 FALL 27 0.0001
519 EXTRAPYRAMIDAL DISORDER 2 0.0001
520 ILEUS 1 0.0001
521 HALLUCINATION 6 0.0001
522 HYPOPHAGIA 2 0.0001
523 DRUG RESISTANCE 2 0.0001
524 INJECTION SITE INDURATION 1 0.0001
525 MUCOSAL INFLAMMATION 2 0.0001
526 ORAL CANDIDIASIS 1 0.0001
527 TOOTH INFECTION 1 0.0001
528 HAIR TEXTURE ABNORMAL 1 0.0001
529 MALIGNANT MELANOMA 1 0.0001
530 QUALITY OF LIFE DECREASED 1 0.0001
531 DRUG INEFFECTIVE 98 0.0001
532 BLOOD BILIRUBIN INCREASED 2 0.0001
533 HEPATIC ENZYME INCREASED 5 0.0001
534 OFF LABEL USE 64 0.0001
535 APPLICATION SITE RASH 1 0.0001
536 RESPIRATORY DISTRESS 2 0.0001
537 FEELING COLD 2 0.0001
538 HAEMOPTYSIS 2 0.0001
539 MASS 1 0.0001
540 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
541 SKIN REACTION 1 0.0001
542 FLATULENCE 4 0.0001
543 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
544 PARALYSIS 1 0.0001
545 IMPAIRED QUALITY OF LIFE 1 0.0001
546 PARAESTHESIA ORAL 1 0.0001
547 HYPOKINESIA 1 0.0001
548 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
549 LIVER FUNCTION TEST ABNORMAL 2 0.0001
550 ACUTE MYOCARDIAL INFARCTION 2 0.0001
551 RESPIRATORY DISORDER 2 0.0001
552 BLOOD POTASSIUM DECREASED 2 0.0001
553 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
554 CONDITION AGGRAVATED 20 0.0001
555 INSURANCE ISSUE 1 0.0001
556 DEVICE RELATED INFECTION 1 0.0001
557 TENDONITIS 1 0.0001
558 PRODUCT USE IN UNAPPROVED INDICATION 16 0.0001
559 DELUSION 1 0.0001
560 THERAPY PARTIAL RESPONDER 1 0.0001
561 BASAL CELL CARCINOMA 1 0.0001
562 NERVOUS SYSTEM DISORDER 2 0.0001
563 DYSPHAGIA 6 0.0001
564 HEAD INJURY 2 0.0001
565 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
566 PNEUMOTHORAX 1 0.0001
567 PREMATURE DELIVERY 1 0.0001
568 OBESITY 1 0.0001
569 ABSCESS 1 0.0001
570 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
571 LOSS OF CONSCIOUSNESS 8 0.0001
572 MOVEMENT DISORDER 2 0.0001
573 HIP FRACTURE 2 0.0001
574 LUNG DISORDER 3 0.0001
575 MANIA 1 0.0001
576 VENTRICULAR TACHYCARDIA 1 0.0001
577 CYTOMEGALOVIRUS INFECTION 1 0.0001
578 INSOMNIA 16 0.0001
579 URINARY RETENTION 2 0.0001
580 BLOOD UREA INCREASED 1 0.0001
581 FACE OEDEMA 1 0.0001
582 CANDIDA INFECTION 1 0.0001
583 SCAR 1 0.0001
584 LOCAL SWELLING 1 0.0001
585 DRUG WITHDRAWAL SYNDROME 5 0.0001
586 LYMPHOCYTE COUNT DECREASED 1 0.0001
587 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
588 LYMPHADENOPATHY 2 0.0001
589 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
590 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
591 DRUG EFFECT INCOMPLETE 2 0.0001
592 PELVIC PAIN 1 0.0001
593 RESTLESS LEGS SYNDROME 1 0.0001
594 HYPERGLYCAEMIA 2 0.0001
595 PANIC ATTACK 2 0.0001
596 TREATMENT NONCOMPLIANCE 3 0.0001
597 MEDICATION ERROR 3 0.0001
598 SEPSIS 6 0.0001
599 THROMBOCYTOPENIA 6 0.0001
600 BACTERIAL INFECTION 1 0.0001
601 MIDDLE INSOMNIA 1 0.0001
602 BLISTER 3 0.0001
603 FOOT FRACTURE 1 0.0001
604 MUSCULOSKELETAL DISORDER 1 0.0001
605 PNEUMONIA 17 0.0001
606 SLEEP APNOEA SYNDROME 1 0.0001
607 MIGRAINE 5 0.0001
608 CHOLESTASIS 1 0.0001
609 DRUG PRESCRIBING ERROR 1 0.0001
610 HERNIA 1 0.0001
611 VISION BLURRED 7 0.0001
612 KIDNEY INFECTION 1 0.0001
613 MEMORY IMPAIRMENT 7 0.0001
614 ASTHENIA 19 0.0001
615 DISORIENTATION 2 0.0001
616 UPPER LIMB FRACTURE 1 0.0001
617 PRODUCT PHYSICAL ISSUE 1 0.0000
618 SUICIDE ATTEMPT 3 0.0000
619 FEEDING DISORDER 1 0.0000
620 TASTE DISORDER 1 0.0000
621 BLINDNESS 2 0.0000
622 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
623 HYPERSENSITIVITY 9 0.0000
624 PERITONITIS 1 0.0000
625 TREATMENT FAILURE 4 0.0000
626 TOOTH LOSS 1 0.0000
627 PULMONARY HYPERTENSION 1 0.0000
628 POLLAKIURIA 2 0.0000
629 PRODUCT USE ISSUE 9 0.0000
630 CARDIO-RESPIRATORY ARREST 2 0.0000
631 DERMATITIS 1 0.0000
632 GAIT DISTURBANCE 9 0.0000
633 JOINT INJURY 1 0.0000
634 RECTAL HAEMORRHAGE 2 0.0000
635 POOR QUALITY SLEEP 1 0.0000
636 OVERDOSE 10 0.0000
637 SWELLING FACE 3 0.0000
638 SEPTIC SHOCK 2 0.0000
639 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
640 PULMONARY OEDEMA 2 0.0000
641 CHROMATURIA 1 0.0000
642 HEART RATE IRREGULAR 1 0.0000
643 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
644 DISEASE PROGRESSION 5 0.0000
645 DISEASE RECURRENCE 2 0.0000
646 MOBILITY DECREASED 3 0.0000
647 DIABETIC KETOACIDOSIS 1 0.0000
648 LOCALISED INFECTION 1 0.0000
649 MENTAL IMPAIRMENT 1 0.0000
650 FIBROMYALGIA 1 0.0000
651 CEREBRAL INFARCTION 1 0.0000
652 LIVER INJURY 1 0.0000
653 BRONCHITIS 3 0.0000
654 HOT FLUSH 3 0.0000
655 SOMNOLENCE 8 0.0000
656 HEPATITIS 1 0.0000
657 CHEST DISCOMFORT 4 0.0000
658 SKIN ULCER 1 0.0000
659 RASH GENERALISED 1 0.0000
660 HAEMATOMA 1 0.0000
661 RESPIRATORY TRACT INFECTION 1 0.0000
662 JOINT STIFFNESS 1 0.0000
663 GASTRITIS 1 0.0000
664 FREQUENT BOWEL MOVEMENTS 1 0.0000
665 LIMB INJURY 1 0.0000
666 RESPIRATORY ARREST 1 0.0000
667 ARTHROPATHY 2 0.0000
668 SKIN EXFOLIATION 3 0.0000
669 EYE PAIN 2 0.0000
670 DEPRESSION 8 0.0000
671 INTENTIONAL DOSE OMISSION 1 0.0000
672 HERPES ZOSTER 2 0.0000
673 BACK PAIN 8 0.0000
674 INTENTIONAL PRODUCT MISUSE 3 0.0000
675 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
676 SURGERY 2 0.0000
677 PREMATURE BABY 1 0.0000
678 HEPATIC FAILURE 1 0.0000
679 NO ADVERSE EVENT 6 0.0000
680 FEELING HOT 2 0.0000
681 PAIN 20 0.0000
682 GYNAECOMASTIA 1 0.0000
683 EXPOSURE DURING PREGNANCY 2 0.0000
684 VOMITING 15 0.0000
685 ANAEMIA 6 0.0000
686 CYSTITIS 1 0.0000
687 MOOD SWINGS 1 0.0000
688 CONTUSION 3 0.0000
689 FATIGUE 24 0.0000
690 PRODUCT DOSE OMISSION 2 0.0000
691 BLOOD CREATININE INCREASED 2 0.0000
692 CHOLELITHIASIS 1 0.0000
693 IMPAIRED HEALING 1 0.0000
694 EYE DISORDER 1 0.0000
695 HEART RATE INCREASED 3 0.0000
696 EXPIRED PRODUCT ADMINISTERED 1 0.0000
697 VIRAL INFECTION 1 0.0000
698 LIP SWELLING 1 0.0000
699 FUNGAL INFECTION 1 0.0000
700 DEHYDRATION 4 0.0000
701 SKIN DISORDER 1 0.0000
702 INJECTION SITE PRURITUS 2 0.0000
703 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
704 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
705 ANGER 1 0.0000
706 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
707 ABDOMINAL PAIN UPPER 6 0.0000
708 ILLNESS 3 0.0000
709 NIGHTMARE 1 0.0000
710 ABDOMINAL DISTENSION 3 0.0000
711 BURNING SENSATION 2 0.0000
712 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
713 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
714 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
715 CEREBRAL HAEMORRHAGE 1 0.0000
716 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
717 CRYING 1 0.0000
718 CONSTIPATION 6 0.0000
719 C-REACTIVE PROTEIN INCREASED 1 0.0000
720 ACCIDENTAL OVERDOSE 1 0.0000
721 PAIN IN EXTREMITY 8 0.0000
722 DYSGEUSIA 2 0.0000
723 HEPATIC FUNCTION ABNORMAL 1 0.0000
724 HYPOAESTHESIA 4 0.0000
725 UNEVALUABLE EVENT 2 0.0000
726 COLITIS 1 0.0000
727 INCORRECT DOSE ADMINISTERED 6 0.0000
728 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
729 HOSPITALISATION 4 0.0000
730 PERIPHERAL SWELLING 4 0.0000
731 PARAESTHESIA 4 0.0000
732 MALAISE 11 0.0000
733 WEIGHT DECREASED 7 0.0000
734 ABORTION SPONTANEOUS 1 0.0000
735 THROMBOSIS 2 0.0000
736 DYSPNOEA 14 0.0000
737 NEUTROPHIL COUNT DECREASED 1 0.0000
738 VISUAL IMPAIRMENT 3 0.0000
739 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
740 ROAD TRAFFIC ACCIDENT 1 0.0000
741 MYALGIA 4 0.0000
742 DEVICE DISLOCATION 1 0.0000
743 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
744 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
745 NEPHROLITHIASIS 1 0.0000
746 TINNITUS 1 0.0000
747 ADVERSE EVENT 2 0.0000
748 NASOPHARYNGITIS 4 0.0000
749 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
750 ABDOMINAL PAIN 5 0.0000
751 BLOOD CHOLESTEROL INCREASED 1 0.0000
752 COUGH 6 0.0000
753 ANXIETY 6 0.0000
754 RENAL CANCER 1 0.0000
755 FEELING ABNORMAL 5 0.0000
756 PRURITUS 8 0.0000
757 INFECTION 3 0.0000
758 HYPOGLYCAEMIA 1 0.0000
759 PRODUCT DOSE OMISSION ISSUE 6 0.0000
760 ALOPECIA 4 0.0000
761 LEUKOPENIA 1 0.0000
762 FLUID RETENTION 1 0.0000
763 BLOOD PRESSURE INCREASED 3 0.0000
764 INFLAMMATION 1 0.0000
765 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
766 NERVOUSNESS 1 0.0000
767 MUSCULOSKELETAL PAIN 1 0.0000
768 BRADYCARDIA 1 0.0000
769 PLATELET COUNT DECREASED 2 0.0000
770 ANAPHYLACTIC REACTION 1 0.0000
771 INFLUENZA 2 0.0000
772 PANCYTOPENIA 1 0.0000
773 ABDOMINAL DISCOMFORT 3 0.0000
774 ASTHMA 2 0.0000
775 NAUSEA 14 0.0000
776 DEATH 15 0.0000
777 EYE IRRITATION 1 0.0000
778 DECREASED APPETITE 4 0.0000
779 COVID-19 3 0.0000
780 BONE PAIN 1 0.0000
781 DIARRHOEA 11 0.0000
782 BLADDER CANCER 1 0.0000
783 CATARACT 1 0.0000
784 PLEURAL EFFUSION 1 0.0000
785 DISCOMFORT 1 0.0000
786 DEVICE EXPULSION 1 0.0000
787 AMNESIA 1 0.0000
788 INFUSION RELATED REACTION 1 0.0000
789 BLOOD PRESSURE DECREASED 1 0.0000
790 PRODUCT QUALITY ISSUE 2 0.0000
791 NEUTROPENIA 2 0.0000
792 INJECTION SITE REACTION 1 0.0000
793 DEVICE MALFUNCTION 1 0.0000
794 INJURY 1 0.0000
795 DIZZINESS 7 0.0000
796 THERAPY INTERRUPTED 1 0.0000
797 UNDERDOSE 1 0.0000
798 WEIGHT INCREASED 3 0.0000
799 EPISTAXIS 1 0.0000
800 DIABETES MELLITUS 1 0.0000
801 CARDIAC FAILURE 1 0.0000
802 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
803 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
804 INFLUENZA LIKE ILLNESS 1 0.0000
805 CEREBROVASCULAR ACCIDENT 2 0.0000
806 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
807 HEADACHE 7 0.0000
808 GASTROINTESTINAL DISORDER 1 0.0000
809 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
810 OROPHARYNGEAL PAIN 1 0.0000
811 DRUG INTOLERANCE 1 0.0000
812 DYSPEPSIA 1 0.0000
813 ERYTHEMA 2 0.0000
814 HAEMORRHAGE 1 0.0000
815 RASH 4 0.0000
816 PALPITATIONS 1 0.0000
817 CHILLS 1 0.0000
818 JOINT SWELLING 1 0.0000
819 EMOTIONAL DISTRESS 1 0.0000
820 OEDEMA PERIPHERAL 1 0.0000
821 INJECTION SITE ERYTHEMA 1 0.0000
822 DRUG DOSE OMISSION 1 0.0000
823 URTICARIA 1 0.0000
824 BLOOD GLUCOSE INCREASED 1 0.0000
825 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
826 ARTHRALGIA 2 0.0000